Yesterday, in response to Chasing Value: ISRG is falling and I'm buying I received the following comment from Beltway Greg, "You're a brave dude. Why? I've watched this stock for awhile and I worry about possible entry by other folks into the market."
Brave perhaps, even foolish on occasion, but I still think this is the time to be selectively buying equities.
The first time I bought Intuitive Surgical Inc (NASDAQ: ISRG) I paid around $7 per share and that is about the lowest point since it went public. Those shares have been sitting in our portfolio as our largest position and our best investment for quite some time.
ISRG makes computer assisted robotic surgical equipment to assist doctors in a growing range of less invasive procedures.
The stock closed yesterday at $214.80. I have been tempted to buy more sh...
I have never figured out why BARRON's does its typical hatchet jobs, which they view as investigative journalism, especially re growth stocks. But it does, so I use articles such as this one as a mechanism to buy on short term price weakness investment opportunities I favor long term. That said, the article is about as even-handed as BARRON's has published, without being mealy-mouthed. The author is fair, and considers what is known, and then predi
Barron's Bill Alpert, a beneficiary of Intuitive Surgical's (ISRG) da Vinci surgical robot after a bout with prostate cancer, has nothing but praise for the company's product - but is more guarded in his outlook for its shares.
Don't allow my ungrateful scrutiny of Intuitive's stock price to blind you to the terrific benefits that the company delivered to patients like me: less surgical trauma; a shorter and cheaper hospital stay; a quicker return to my supposedly productive work.
This week's Barron's (subscription required) finally had Intuitive Surgical (NASDAQ: ISRG) on its cover, and cover it it did, but with a wet blanket.
The stock is down in early trading today, but that is probably warranted given the runup last week when it jumped $52 in one day after it reported one more mind boggling quarter. I only exaggerate slightly as the company beat estimates by 10 cents a share and increased margins in all areas, when I reported then...
Yes, I perceive this phase of the market decline (in place since May) is probably complete, and the entire decline (bear market, whatever) that began approximately 9 months ago, in October 2007, is possibly complete. Readers of this blog have their buy lists ready, and recognize specific investment opportunities actionable in his or her time frame.
My favorite company, Intuitive Surgical Inc. (NASDAQ: ISRG), the maker of the da Vinci Surgical System reported earnings Tuesday afternoon that creamed Street guesstimates by 10 cents per share. Intuitive posted earnings per share of $1.28 versus analyst consensus of $1.18.
For the 23rd quarter in a row, just like clockwork and without missing a beat, Intuitive's top and bottom li
Big rally next week with ISRG and AAPL reporting earnings. ISRG could gain 10% by the end of the week and another 10-20% by next month. Believe it. It may look expensive but take into consideration it's growth and it will look cheap. I know insurence companies have been off but people are still getting medical proceedures done and hospitals are still opening all over texas and other states. ISRG is a must if your looking for short term gains.
The company must continue to show value-add for customer capital spending and expand physician acceptance. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect.
Long time readers recognize that I view trends differently thanmost chart readers, including how and when trends die and reverse. Forexample, there was my recommendation to sell 1/2 of our position in Intuitive Surgical (ISRG) at~$335, while Wall Street (Jim Cramer included) were ga-ga for theshares.<!----> Although not explained at the time, one perception I employ isthe difference between the momentum, price, and breadthhigh prices. (And vice-versa for the low prices.) Market watchers willrecognize these chart points as double, triple, and head & shouldertops (and bottoms); I prefer to se
It was reported today that robotic surgery company Intuitive Surgical, Inc. (NASDAQ: ISRG) may not meet analysts average revenue expectations for 2008 and this is driving shares down $7.00 hovering around $281 per share.
Although the company guidance discussed figures around $850 million while the analysts were GUESSING $873 million temporary disappointment is affecting trading. Despite this, Eli Kammerman of Cowen & Co is maintaining his "Outpe
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.